Literature DB >> 20523255

Exposed porous orbital implants treated with simultaneous secondary implant and dermis fat graft.

Brian J Lee1, Craig D Lewis, Julian D Perry.   

Abstract

PURPOSE: To describe a technique for simultaneous secondary orbital implantation and dermis fat graft placement for exposed porous implants with significant conjunctival insufficiency.
DESIGN: Retrospective review of 4 consecutive cases.
METHODS: Charts were reviewed for type and size of exposed porous implant, size of conjunctival defect, history of previous reconstruction for exposure, size and type of implant placed, follow-up interval, complications, ability to retain prosthesis, and cosmesis.
RESULTS: Four patients underwent simultaneous dermis fat graft placement and secondary implantation for exposed and completely avascular orbital implants. The rectus muscles were advanced over the new implant to act as the host bed for the dermis fat graft. All patients tolerated a new prosthesis well, with adequate motility and cosmesis.
CONCLUSIONS: Simultaneous secondary implantation and dermis fat graft placement may adequately address avascular porous implant exposure with significant conjunctival insufficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20523255     DOI: 10.1097/IOP.0b013e3181bf24db

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Helium-neon laser therapy in the treatment of hydroxyapatite orbital implant exposure: A superior option.

Authors:  Qi-Hua Xu; Chen Zhao; Jian-Gang Zhu; Mei-Juan Chen; Qing-Huai Liu
Journal:  Exp Ther Med       Date:  2015-06-23       Impact factor: 2.447

2.  Indications and results in anophthalmic socket reconstruction using dermis-fat graft.

Authors:  Orapan Aryasit; Passorn Preechawai
Journal:  Clin Ophthalmol       Date:  2015-05-04

3.  Use of extraocular muscle flaps in the correction of orbital implant exposure.

Authors:  Hsueh-Yen Chu; Yi-Lin Liao; Yueh-Ju Tsai; Yen-Chang Chu; Shu-Ya Wu; Lih Ma
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.